Publications - Page 4 sur 57 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Fibrose pulmonaire - FPI
Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis: A Bidirectional Mendelian Randomisation Study

Leavy, Olivia C., Leticia Kawano-Dourado, Iain D. Stewart, Jennifer K. Quint, Joshua J. Solomon, Raphael Borie, Bruno Crestani, et al.

Thorax 79, nᵒ 6 (mai 2024): 538‑44.
Fibrose pulmonaire - FPI
Anti-Mutated Citrullinated Vimentin Antibodies Are Increased in IPF Patients

Le Guen, Pierre, Coralie Tardivon, Cédric Laouénan, Marie-Pierre Debray, Pascale Nicaise Roland, Camille Taillé, Raphael Borie, et al.

Respiratory Medicine and Research 85 (juin 2024): 101081.
Fibrose pulmonaire - FPI
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

Lancaster, Lisa, Vincent Cottin, Murali Ramaswamy, Wim A. Wuyts, R. Gisli Jenkins, Mary Beth Scholand, Michael Kreuter, et al.

American Journal of Respiratory and Critical Care Medicine 210, nᵒ 4 (août 2024): 424‑34.
Fibrose pulmonaire - FPI
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease

Johannson, Kerri A., Ayodeji Adegunsoye, Jürgen Behr, Vincent Cottin, Allan R. Glanville, Marilyn K. Glassberg, Gillian C. Goobie, et al.

American Journal of Respiratory and Critical Care Medicine, janvier 2025.
Fibrose pulmonaire - FPI
Effects of Nintedanib on Circulating Biomarkers of Idiopathic Pulmonary Fibrosis

Jenkins, R. Gisli, Vincent Cottin, Yasuhiko Nishioka, Imre Noth, Eric S. White, Carina Ittrich, Claudia Diefenbach, Klaus B. Rohr, Moisés Selman, et Toby M. Maher

ERJ Open Research 10, nᵒ 6 (novembre 2024): 00558‑02023.
Fibrose pulmonaire - FPI
Pulmonary Fibrosis in Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Nationwide Cohort Study

Guirriec, Yoann, David Luque-Paz, Gontran Bernard, Axelle Mabo, Mallorie Kerjouan, Cédric Ménard, Delphine Monnier, et al.

ERJ Open Research 10, nᵒ 6 (décembre 2024): 00314‑02024
Fibrose pulmonaire - FPI
U-Net Convolutional Neural Network Applied to Progressive Fibrotic Interstitial Lung Disease: Is Progression at CT Scan Associated with a Clinical Outcome?

Guerra, Xavier, Simon Rennotte, Catalin Fetita, Marouane Boubaya, Marie-Pierre Debray, Dominique Israël-Biet, Jean-François Bernaudin, et al.

Respiratory Medicine and Research 85 (juin 2024): 101058
Fibrose pulmonaire - FPI
Identification of FGFR4 as a Regulator of Myofibroblast Differentiation in Pulmonary Fibrosis

Ghanem, Mada, Aurélien Justet, Madeleine Jaillet, Eirini Vasarmidi, Tiara Boghanim, Mouna Hachem, Aurélie Vadel, et al.

American Journal of Physiology. Lung Cellular and Molecular Physiology 327, nᵒ 6 (décembre 2024): L818‑30.
Fibrose pulmonaire - FPI
FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis

Ghanem, Mada, Gabrielle Archer, Aurélien Justet, Madeleine Jaillet, Eirini Vasarmidi, Pierre Mordant, Yves Castier, et al.

American Journal of Respiratory and Critical Care Medicine 211, nᵒ 3 (mars 2025): 486‑98.
Fibrose pulmonaire - FPI
Lack of Efficacy of Tocilizumab in Acute Exacerbation of Pulmonary Fibrosis

Franco, Giovanni, Pierre Le Guen, Mathilde Le Brun, Quentin Philippot, Clairelyne Dupin, Marie-Pierre Debray, Catherine Bancal, Camille Taillé, Raphaël Borie, et Bruno Crestani.

ERJ Open Research 10, nᵒ 6 (décembre 2024): 00520‑02024.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Rheumatoid Arthritis and Idiopathic Pulmonary Fibrosis: A Bidirectional Mendelian Randomisation Study

Anti-Mutated Citrullinated Vimentin Antibodies Are Increased in IPF Patients

Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial

Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease

Effects of Nintedanib on Circulating Biomarkers of Idiopathic Pulmonary Fibrosis

Pulmonary Fibrosis in Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Nationwide Cohort Study

U-Net Convolutional Neural Network Applied to Progressive Fibrotic Interstitial Lung Disease: Is Progression at CT Scan Associated with a Clinical Outcome?

Identification of FGFR4 as a Regulator of Myofibroblast Differentiation in Pulmonary Fibrosis

FGF21 Signaling Exerts Antifibrotic Properties during Pulmonary Fibrosis

Lack of Efficacy of Tocilizumab in Acute Exacerbation of Pulmonary Fibrosis